Author

Morgan E. Roberts

Observed names: M E Roberts, M Roberts, M. E. Roberts, M.E. Roberts, Morgan E Roberts, Morgan Roberts, Roberts, Morgan, Roberts, Morgan E

Observed institutions: BC Cancer Agency, Montreal Neurological Institute and Hospital, Vancouver Coastal Health, University of British Columbia, University of Nottingham, University of Michigan, Kyushu University Hospital, Queen's Medical Centre, Vancouver Coastal Health Research Institute, Vancouver Prostate Centre, McGill University

ORCID: 0000-0002-5850-7985

Observed ORCID: 0000-0002-5850-7985

OpenAlex ID: A5047068321

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

2014 · Jennifer L. Bishop, Alexander Sio, et al. · Oncotarget · 279

PDF

Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

2017 · Manav Korpal, Xiaoling Puyang, et al. · Nature Communications · 143

PDF

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis

2018 · Peter J. Darlington, Brandon Stopnicki, et al. · Frontiers in Immunology · 79

PDF

Dysregulated Hematopoiesis Caused by Mammary Cancer Is Associated with Epigenetic Changes and Hox Gene Expression in Hematopoietic Cells

2013 · Alexander Sio, Manreet K. Chehal, et al. · Cancer Research · 46

Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells

2013 · J L Bishop, M E Roberts, et al. · Mucosal Immunology · 44

Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production

2010 · M.E. Roberts, L. Magowan, et al. · European Respiratory Journal · 43

PDF

Targeting Lyn regulates Snail family shuttling and inhibits metastasis

2017 · D Thaper, S Vahid, et al. · Oncogene · 39

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma

2020 · Ninadh M. D’Costa, Matthew R. Lowerison, et al. · Journal of Experimental & Clinical Cancer Research · 32

PDF

Deep Phenotyping by Mass Cytometry and Single-Cell RNA-Sequencing Reveals LYN-Regulated Signaling Profiles Underlying Monocyte Subset Heterogeneity and Lifespan

2020 · Morgan E. Roberts, Maunish Barvalia, et al. · Circulation Research · 31

Lyn Deficiency Leads to Increased Microbiota-Dependent Intestinal Inflammation and Susceptibility to Enteric Pathogens

2014 · Morgan E Roberts, Jennifer L Bishop, et al. · The Journal of Immunology · 23

Pulsed Photothermal Therapy of Solid Tumors as a Precondition for Immunotherapy

2024 · Negin Farivar, Nastaran Khazamipour, et al. · Small · 19

Recent progress with next‐generation biomarkers in muscle‐invasive bladder cancer

2016 · Alberto Contreras‐Sanz, Morgan E Roberts, et al. · International Journal of Urology · 14

PDF

Development of a bispecific immune engager using a recombinant malaria protein

2021 · Mie A. Nordmaj, Morgan E. Roberts, et al. · Cell Death and Disease · 12

PDF

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy

2025 · A. Contreras-Sanz, G. L. Negri, et al. · Nature Communications · 11

PDF

CCR 3 induced‐p42/44 MAPK activation protects against staurosporine induced‐ DNA fragmentation but not apoptosis in airway smooth muscle cells

2012 · L. J. Markwick, D. Clements, et al. · Clinical & Experimental Allergy · 10

Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors

2024 · Nastaran Khazamipour, Htoo Zarni Oo, et al. · EMBO Molecular Medicine · 8

PDF

A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer

2023 · Davide Tortora, Morgan E. Roberts, et al. · iScience · 8

Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

2019 · Manav Korpal, Xiaoling Puyang, et al. · Nature Communications · 4

PDF

FBXW7 loss of function contributes to worse overall survival and is associated with accumulation of MYC in muscle invasive bladder cancer

2020 · T Matumoto, Y Chen, et al. · Urologic Oncology Seminars and Original Investigations · 3

Immuno-oncology of Dormant Tumours

2017 · Noushin Nabavi, Morgan E. Roberts, et al. · Cancer drug discovery and develogment/Cancer drug discovery and development · 3

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy

2024 · Alberto Contreras-Sanz, Gian Luca Negri, et al. · Research Square · 2

A marrow-minded look at immune checkpoint blockade resistance in metastatic castration resistant prostate cancer

2021 · Nicolette M. Fonseca, Morgan E. Roberts, et al. · Translational Andrology and Urology · 2

PDF

B cell exhaustion associates with poor response to Bacillus Calmette-Guérin immunotherapy in patients with bladder cancer

2026 · Priyanka Yolmo, Kartik Sachdeva, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

PDF

Establishing a Foundation for Studying the Immune Contexture Across the Spectrum of Bladder Cancer

2022 · Morgan E. Roberts, Alberto Contreras-Sanz, et al. · European Urology Oncology · 1

Local and systemic modulation of the PD-L1 pathway is a novel mechanism of Enzalutamide resistance in castration-resistant prostate cancer

2014 · Jennifer Bishop, Alexander Sio, et al. · Journal for ImmunoTherapy of Cancer · 1

PDF

Works count: 46

Citation count: 856

H-index: 12

I10-index: 15